IMUNON, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-15, effective July 25, 2025, in order to meet Nasdaq's minimum bid price requirement. This decision follows ...
Ekso Bionics will implement a 1-for-15 reverse stock split effective May 27, 2025, to improve its stock price compliance. Ekso Bionics Holdings, Inc., a developer of exoskeletons for medical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results